AN ABERDEEN biotech firm has won £1.8 million of funding to help develop a treatment to combat life-threatening fungal infections, writes Scott Wright.
NovaBiotics secured the cash in a research competition, led by the Department of Health and Social Care (DHSC), aimed at tackling antimicrobial resistance in humans.
It will use the funding to further develop Novamycin, described as a first-in-class antifungal compound with a potential to combat life threatening and drug resistance blood stream and tissue fungal infections.
The company, established in 2004, said Novamycin is active against fungi, including drug resistant forms, for which existing therapies do not work. It said Novamycin utilises the natural antifungal defence system employed by the body, in contrast to other antifungal agents which it says do not always distinguish healthy human cells from a fungal pathogen.
Dr Deborah O’Neil, chief executive of NovaBiotics, said: “This award allows us to accelerate the next key stage of Novamycin’s development towards being a much-needed solution to life threatening fungal infections against which the limited number of existing therapies are ineffective. This is a somewhat neglected and under-invested area of antimicrobial research”.
Why are you making commenting on The Herald only available to subscribers?
It should have been a safe space for informed debate, somewhere for readers to discuss issues around the biggest stories of the day, but all too often the below the line comments on most websites have become bogged down by off-topic discussions and abuse.
heraldscotland.com is tackling this problem by allowing only subscribers to comment.
We are doing this to improve the experience for our loyal readers and we believe it will reduce the ability of trolls and troublemakers, who occasionally find their way onto our site, to abuse our journalists and readers. We also hope it will help the comments section fulfil its promise as a part of Scotland's conversation with itself.
We are lucky at The Herald. We are read by an informed, educated readership who can add their knowledge and insights to our stories.
That is invaluable.
We are making the subscriber-only change to support our valued readers, who tell us they don't want the site cluttered up with irrelevant comments, untruths and abuse.
In the past, the journalist’s job was to collect and distribute information to the audience. Technology means that readers can shape a discussion. We look forward to hearing from you on heraldscotland.com
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules hereLast Updated:
Report this comment Cancel